Section : Patentability of biotechnological inventions | Patentability in healthcare, biotechnology and chemistry | e-learning centre
Page principale du coursPatentability of biotechnological inventions
-
Patentability of biotechnological inventions
-
Recorded webinar: Post-published evidence – a risky game!
Watch the recorded webinar on post-published evidence and the conditions in which it is taken into account, held by Katell Le Flao, examiner in the sector HBC-cancer immunology at the EPO. You can use the links below the video in order to directly access specific sections of the webinar or questions asked by the participants.
-
Recorded webinar: Experimental data: impact on patentability in medical applications
Watch the recorded webinar on experimental data and its impact on patentability in medical applications, held by Elsie Cielen, examiner in the field of 2nd medical applications at the EPO and Britta Kley, lawyer in the Directorate Patent Law at the EPO. You can use the links below the video in order to directly access specific sections of the webinar or questions asked by the participants.
This webinar was recorded in December 2018. Its content is still valid but should be considered in the light of G 2/21 issued on 23 March 2023, where the Enlarged Board of Appeal concluded that the term "plausibility" did not amount to a distinctive legal concept or a specific patent law requirement.
-